6'-Sialyllactose (6'-SL) represents one of the most significant human milk oligosaccharides (HMOs), playing a critical role in neonatal brain development, immune modulation, and the establishment of a healthy gut microbiome. As a trisaccharide composed of N-acetylneuraminic acid (Neu5Ac) linked to the C-6 position of the galactose residue in lactose, 6'-SL is notoriously difficult to extract from natural sources at scale. CD BioGlyco leverages a proprietary Synthetic Glycobiology Platform to overcome the limitations of traditional extraction and chemical synthesis. Our 6'-SL production service provides high-purity, bio-identical HMOs designed for researchers and product developers in the nutraceutical, pharmaceutical, and infant formula sectors. By utilizing metabolic engineering and high-efficiency fermentation, we ensure a sustainable and scalable supply of this vital glycan.
Core Technologies
Our production excellence is rooted in two primary pillars:
Precision Metabolic Engineering
We utilize CRISPR/Cas9 and advanced pathway modeling to optimize microbial hosts (typically E. coli K-12 or S. cerevisiae). This involves upregulating the sialic acid biosynthesis pathway while silencing competing metabolic routes to maximize 6'-SL yield.
Enzymatic Tailoring & Biotransformation
For specialized applications, we employ recombinant ɑ2,6-sialyltransferases with enhanced thermal stability and substrate affinity, ensuring the specific ɑ2,6 linkage is formed with 100% regioselectivity, eliminating the presence of unwanted isomers like 3'-SL.
Bridging the Gap Between Nature and Nutrition through Synthetic Glycobiology.
The 6'-SL production service is a comprehensive solution designed to move your project from theoretical design to commercial reality. Our scope covers the entire value chain of HMO production. We provide custom scale-up services ranging from milligram pilot studies for academic research to multi-kilogram batches for clinical trials and product formulation.
Our service extends beyond simple manufacturing; we offer deep analytical characterization to ensure that every batch of 6'-SL meets the rigorous standards for safety and bioequivalence. This includes impurity profiling, heavy metal analysis, and stability testing across various temperature and humidity profiles. We specifically cater to the needs of the infant nutrition industry, where 6'-SL is increasingly recognized for its role in preventing pathogen adhesion and promoting the growth of Bifidobacterium. Furthermore, our expertise in synthetic glycobiology allows us to modify the production strain to co-produce other sialylated or fucosylated glycans, offering a modular approach to HMO blend development. CD BioGlyco remains committed to providing a transparent, documented, and highly efficient manufacturing pipeline.
Workflow
Strain Customization
We initiate the production platform with the careful selection and genetic optimization of a robust microbial host. The ideal chassis is chosen based on its native tolerance to metabolic stress and its capacity for genetic manipulation. A primary engineering focus is enhancing its resistance to sialic acid accumulation, which can be inhibitory, by modulating relevant transporters and regulatory networks. Concurrently, we optimize the host's ability to internalize and utilize lactose, the essential acceptor molecule. This is achieved by engineering high-affinity lactose permease systems and eliminating competing catabolic pathways. The entire sialyllactose biosynthetic cassette, including genes for precursor synthesis and the specific α-2,6-sialyltransferase for 6'-SL, is then integrated and codon-optimized within this customized host to ensure maximum pathway flux and stability.
Upstream Fermentation
Production is conducted in high-capacity, computer-controlled bioreactors equipped with advanced process analytical technology (PAT). We implement a controlled-growth fed-batch strategy, where the feeding of key nutrients, particularly the carbon source and lactose, is dynamically adjusted based on real-time feedback. Critical parameters, including pH, dissolved oxygen (DO), temperature, and substrate concentrations, are monitored continuously. This data-driven approach allows for precise maintenance of the optimal physiological state, balancing high biomass growth with a sustained, high-yield production phase dedicated to 6'-SL synthesis, thereby maximizing volumetric productivity.
Cell Disruption & Recovery
At the conclusion of fermentation, the 6'-SL-rich broth is efficiently harvested. The biomass is separated from the extracellular product-containing medium using a solid-liquid separation process, typically continuous centrifugation or tangential flow microfiltration. This primary clarification step effectively removes the bulk of cells and large particulate matter, resulting in a clarified supernatant. This step is optimized for maximum product recovery while minimizing the carryover of host cell proteins and nucleic acids into the downstream purification stream.
Downstream Purification
The clarified broth undergoes a proprietary, multi-stage purification sequence. An initial capture and purification step often involves ion-exchange chromatography, which exploits the charged nature of 6'-SL to separate it from neutral sugars and many other impurities. This is followed by a polishing stage using nanofiltration, a membrane process that removes residual salts, small organic molecules, and any potential microbial contaminants based on size and charge. The integrated process is designed to consistently yield 6'-SL with a combined chemical and microbial purity exceeding 98%, meeting stringent quality standards.
Analytical Validation
The identity, purity, and concentration of every batch are rigorously confirmed using a suite of orthogonal analytical techniques. High-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) provides high-resolution separation and accurate quantification of 6'-SL relative to any carbohydrate impurities. Nuclear magnetic resonance (NMR) spectroscopy, particularly 1H NMR, offers definitive proof of molecular structure by confirming the characteristic α-2,6 glycosidic linkage and the anomeric configuration. These analyses together verify the product's structural integrity and absolute concentration.
Dehydration & Packaging:
The purified 6'-SL solution is converted into a stable solid form suitable for storage and transportation. This is achieved through gentle dehydration processes, either lyophilization (freeze-drying) for maximal structural preservation or controlled spray-drying for efficient bulk powder production. Both methods yield a fine, highly soluble powder with low moisture content and excellent flow properties. The final powder is packaged under inert atmospheric conditions (e.g., nitrogen) in moisture-proof containers to ensure long-term stability and shelf-life by preventing degradation, caking, or microbial growth.
Publication Data
Journal: Nutrients
DOI: 10.3390/nu16162600
IF: 5.0
Published: 2024
Results: The authors of this study investigated the effects of 6'-SL, a human milk oligosaccharide, on exercise performance and muscle functions in young male C57BL/6J mice, addressing a gap in knowledge regarding its efficacy under normal conditions. They orally administered 100 mg/kg of 6'-SL daily for 12 weeks and conducted exhaustive treadmill tests, which revealed significant enhancements in running distance, exhaustion time, and work output. Grip strength measurements also showed a marked increase over time. Post-sacrifice analyses demonstrated that 6'-SL treatment led to greater muscle mass in the gastrocnemius and soleus muscles, along with larger muscle fiber diameters and elevated protein expression of total myosin heavy chain. These morphological and molecular changes collectively indicate that 6'-SL improves endurance and strength by promoting muscle hypertrophy, suggesting its potential as a safe and effective dietary supplement for enhancing physical performance in athletes and fitness enthusiasts.
Application
Cognitive Health Research
Investigating the role of sialylated glycans in sialic acid delivery to the brain, potentially improving memory and learning capabilities in developmental models.
Immune Modulation
Utilizing 6'-SL to study the inhibition of viral and bacterial adhesion to mucosal surfaces, offering a non-antibiotic approach to infection prevention.
Pharmaceutical Intermediates
Using 6'-SL as a complex carbohydrate building block for the synthesis of more elaborate glyconjugates or glycomimetics.
Anti-Inflammatory Research
Exploring the ability of 6'-SL to modulate inflammatory signaling pathways in the intestinal epithelium and beyond.
Advantages
Unrivaled Regioselectivity
Our proprietary technology platform is engineered to deliver absolute specificity for the α2,6 sialyllactose (6'-SL) linkage. This is achieved through the exclusive use of highly optimized α-2,6-sialyltransferases, sourced and engineered for maximal fidelity. Unlike enzymatic or whole-cell methods that can produce mixtures of 2,3- and 2,6-linked isomers, our process eliminates the formation of 3'-SL (α2,3-sialyllactose) at the biosynthetic level.
Scalable Infrastructure
Our end-to-end manufacturing capabilities are built on a seamlessly integrated infrastructure designed for agile and reliable scale-up. We operate a dedicated, modular suite of fermenters ranging from bench-scale for process development and strain optimization to fully automated pilot (200L) and commercial production-scale bioreactors. This continuum, supported by matched downstream processing lines, allows for the rapid and efficient translation of validated laboratory protocols to industrial production.
Sustainability Driven
We are committed to an environmentally responsible manufacturing paradigm. Our core production process utilizes microbial fermentation with renewable, plant-derived feedstocks such as glucose and glycerol as primary carbon sources. This biotechnological approach significantly reduces reliance on petrochemical precursors and harsh reagents associated with traditional chemical synthesis.
Comprehensive Analytics
Quality and transparency are paramount. Each batch of our product is subjected to a rigorous, multi-parameter analytical release protocol. Every shipment is accompanied by a detailed certificate of analysis (CoA) that provides full traceability and quantitative validation. This certificate includes critical data from high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) for precise carbohydrate profiling and purity assessment, coupled with mass spectrometry (LC-MS) for unambiguous molecular identity confirmation.
Frequently Asked Questions
Customer Review
"The purity of the 6'-SL provided by CD BioGlyco was instrumental in our recent clinical study. Their analytical support is second to none."
– Dr. A. Chen, Senior Scientist, Pediatric Nutrition Dept
"Switching to CD BioGlyco for our HMO supply significantly reduced our production lead times. Their technical team is highly responsive."
– Manager, R&D, Dietary Supplements Division
"Finding a reliable source of 6'-SL with no 3'-SL contamination was a challenge until we partnered with CD BioGlyco. Their material is exceptionally consistent."
– Dr. S. Miller, Principal Investigator, Glycobiology Research
"The scalability of CD BioGlyco's platform allowed us to move from prototype to pilot testing much faster than we anticipated."
– Director of Innovation, Functional Foods Department
Associated Services
Recombinant Type I Human Collagen Production Service
High-purity collagen for tissue engineering and medical applications.
Recombinant Type III Human Collagen Production Service
Specialized collagen for wound healing and dermatological research.
Recombinant Human-like Collagen Production Service
Biocompatible collagen scaffolds for advanced regenerative medicine.
CD BioGlyco stands at the forefront of HMO production, offering a sophisticated 6'-SL production service that combines the precision of synthetic biology with the reliability of industrial fermentation. We are dedicated to providing our clients with the high-purity glycans necessary to drive innovation in human health and nutrition. For detailed technical specifications, pricing, or to discuss a custom production project, please contact us.
Reference
Park, E.J.; et al. 6'-Sialyllactose enhances exercise performance via increased muscle mass and strength. Nutrients. 2024, 16(16): 2600. (Open Access)
For research use only. Not intended for any clinical use.
